S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
PwC Australia sidelines 9 directors as leak of tax information investigated
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
3 Free Stock Picks per Day (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
NYSE:SNN

Smith & Nephew (SNN) Stock Forecast, Price & News

$30.07
+0.15 (+0.50%)
(As of 05/26/2023 07:00 PM ET)
Compare
Today's Range
$30.00
$30.20
50-Day Range
$27.38
$32.70
52-Week Range
$21.77
$33.08
Volume
848,600 shs
Average Volume
851,707 shs
Market Capitalization
$13.13 billion
P/E Ratio
N/A
Dividend Yield
2.99%
Price Target
N/A

Smith & Nephew MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.30% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.60mentions of Smith & Nephew in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.77%
From $1.74 to $1.91 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.62 out of 5 stars

Medical Sector

919th out of 1,010 stocks

Surgical Appliances & Supplies Industry

19th out of 20 stocks


SNN stock logo

About Smith & Nephew (NYSE:SNN) Stock

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SNN Stock News Headlines

Get MarketBeat All Access Free for 30 Days
MarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock picks, best-in-class research tools, real-time alerts, proprietary research reports and much more. Try it free for 30 days.
Smith & Nephew (NYSE:SNN) Lowered to Hold at HSBC
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Smith & Nephew Buy Write
Smith & Nephew (NYSE:SNN) Upgraded at Morgan Stanley
Smith & Nephew (NYSE:SNN) Cut to Underweight at Barclays
Smith & Nephew rises Tuesday, outperforms market
Smith & Nephew: Flat FY22 Growth, Now An Execution Story
Investors’ Chronicle: Antofagasta, Hays, Smith & Nephew
What Makes Smith & Nephew (SNN) a New Buy Stock
See More Headlines
Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SNN Company Calendar

Last Earnings
11/17/2014
Ex-Dividend for 5/17 Dividend
3/30/2023
Dividend Payable
5/17/2023
Today
5/29/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Employees
19,012
Year Founded
1856

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.22 billion
Cash Flow
$3.06 per share
Book Value
$12.08 per share

Miscellaneous

Free Float
432,321,000
Market Cap
$13.13 billion
Optionable
Optionable
Beta
0.60

Social Links


Key Executives

  • Deepak S Nath
    Chief Executive Officer & Director
  • Paul Connolly
    President-Global Operations
  • Anne-Francoise Nesmes
    Chief Financial Officer & Executive Director
  • Alison Parkes
    Chief Compliance Officer
  • Philip G. Cowdy
    Chief Business Development Officer













SNN Stock - Frequently Asked Questions

Should I buy or sell Smith & Nephew stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 2 sell ratings, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SNN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNN, but not buy additional shares or sell existing shares.
View SNN analyst ratings
or view top-rated stocks.

How have SNN shares performed in 2023?

Smith & Nephew's stock was trading at $26.89 at the start of the year. Since then, SNN stock has increased by 11.8% and is now trading at $30.07.
View the best growth stocks for 2023 here
.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,300,000 shares, an increase of 25.0% from the April 30th total of 1,040,000 shares. Based on an average daily trading volume, of 931,300 shares, the short-interest ratio is currently 1.4 days. Currently, 0.3% of the shares of the company are short sold.
View Smith & Nephew's Short Interest
.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) posted its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.59.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew announced a semi-annual dividend on Monday, February 27th. Stockholders of record on Friday, March 31st will be given a dividend of $0.462 per share on Wednesday, May 17th. This represents a dividend yield of 2.6%. The ex-dividend date is Thursday, March 30th. This is a boost from the stock's previous semi-annual dividend of $0.29.
Read our dividend analysis for SNN
.

What ETFs hold Smith & Nephew's stock?

ETFs with the largest weight of Smith & Nephew (NYSE:SNN) stock in their portfolio include ALPS Disruptive Technologies ETF (DTEC).SPDR S&P Kensho New Economies Composite ETF (KOMP).

Is Smith & Nephew a good dividend stock?

Smith & Nephew (NYSE:SNN) pays an annual dividend of $0.90 per share and currently has a dividend yield of 3.01%.
Read our dividend analysis for SNN.

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Alexion Pharmaceuticals (ALXN) and Amgen (AMGN).

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

Who are Smith & Nephew's major shareholders?

Smith & Nephew's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Nuance Investments LLC (2.43%), Arrowstreet Capital Limited Partnership (0.59%), Scharf Investments LLC (0.51%), FMR LLC (0.46%), Bank of America Corp DE (0.23%) and Envestnet Asset Management Inc. (0.19%).

How do I buy shares of Smith & Nephew?

Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $30.07.

How much money does Smith & Nephew make?

Smith & Nephew (NYSE:SNN) has a market capitalization of $13.13 billion and generates $5.22 billion in revenue each year.

How many employees does Smith & Nephew have?

The company employs 19,012 workers across the globe.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE. The official website for the company is www.smith-nephew.com. The medical equipment provider can be reached via phone at 441923477100, via email at andrew.swift@smith-nephew.com, or via fax at 44-20-7930-3353.

This page (NYSE:SNN) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -